
We are uniquely qualified to Design & Execute Clinical Trials, and in particular help Rescue US Clinical Trials and Address Delayed FDA Submissions. Our team provides unique insight that comes from years of conducting clinical research. Drs. Mehra and Zhang have extensive Biostatistics and Clinical Data Management expertise developed over many years of working with the FDA to bring new drugs to market. Drs. Spilker and Tansey are widely published and acknowledged industry experts. Dr. Ryan enjoys significant Regulatory experience, and Dr. Price is an expert in drug safety issues. Each member our team has between 20 and 30 years experience in the design and execution of clinical trials. During his career, Dr. Mehra has helped lead two CROs through rapid growth, one of which went public in 1991.